Trademark: 88855023
Word
DELIGASE
Status
Registered
Status Code
700
Status Date
Tuesday, July 6, 2021
Serial Number
88855023
Registration Number
6412399
Registration Date
Tuesday, July 6, 2021
Mark Type
4000
Filing Date
Tuesday, March 31, 2020
Published for Opposition
Tuesday, August 4, 2020

Trademark Owner History
Nurix Therapeutics, Inc. - Original Registrant

Classifications
42 Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform

Trademark Events
Jul 6, 2021
Registered-Principal Register
Jun 2, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 1, 2021
Allowed Principal Register - Sou Accepted
May 14, 2021
Teas/Email Correspondence Entered
May 14, 2021
Correspondence Received In Law Office
May 14, 2021
Teas Response To Office Action Received
Mar 5, 2021
Teas Extension Received
Nov 18, 2020
Notification Of Non-Final Action E-Mailed
Nov 18, 2020
Non-Final Action E-Mailed
Nov 18, 2020
Su - Non-Final Action - Written
Oct 29, 2020
Statement Of Use Processing Complete
Oct 12, 2020
Use Amendment Filed
Oct 28, 2020
Case Assigned To Intent To Use Paralegal
Oct 12, 2020
Teas Statement Of Use Received
Sep 29, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2020
Published For Opposition
Jul 15, 2020
Notification Of Notice Of Publication E-Mailed
Jul 2, 2020
Assigned To Lie
Jun 29, 2020
Approved For Pub - Principal Register
Jun 29, 2020
Examiner's Amendment Entered
Jun 29, 2020
Notification Of Examiners Amendment E-Mailed
Jun 29, 2020
Examiners Amendment E-Mailed
Jun 29, 2020
Examiners Amendment -Written
Jun 19, 2020
Assigned To Examiner
Apr 7, 2020
New Application Office Supplied Data Entered In Tram
Apr 3, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24